Treatment of relapsed/refractory multiple myeloma (RRMM) is challenging as patients exhaust all available therapies and the disease becomes refractory to standard drug classes. Here we report the ...

Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include ...